In-Person Pass | Register for Free
The Financial Times, in partnership with Syneos Health, is bringing together investors, biotechs and big pharma for part two of the Funding Biopharma Innovation series.
Join us in person in New York on June 26 as we explore how to create the competitive advantage that enables emerging biotechs to stand out from their peers.
This event is designed to meet the needs of senior leaders in the biotech and pharma industry and life science venture capital executives and partners.
Places are limited and all applications are subject to approval from the publisher.
Please register your details and a member of the team will get back to you.
Apply to Attend
Receive exclusive personalised training and events invitations, carefully-curated offers and promotions from Financial Times by Email
Receive exclusive personalised events invitations, carefully-curated offers and promotions from Financial Times by Phone
Receive information from Syneos Health by email about their products and services.
Receive information from Syneos Health by phone about their products and services.
By checking this box, you agree to our End User Terms and Privacy Policy.
<div style="text-align: center; font-size:22px;"> Thank you for applying to attend Funding Biopharma Innovation, taking place on June 26 in New York City. A member of our team will get back to you within 3 working days. </div>
Please note that complimentary places are available only to individuals who meet our qualifying criteria as outlined on this website and are subject to review and approval by the Publisher. If for any chance you do not meet criteria we will notify you. FT reserves the right, without any liability, to refuse you access or eject you from the Event for failure to comply with these Terms.
Please be aware that the registration form and live broadcast will not work on Internet Explorer.
If you are experiencing technical difficulties please see our Help page or contact our team for more information:
ftlive@ft.com | +44 (0) 207 775 6653
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice